Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-016515

Chief Operating Officer sold 25,000 shares at an average $54.00 ($1,350,000)

  • Chief Operating Officer acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya Chief Operating Officer 2024-02-14 Option exercise 10b5-1 +5,000 $23.04 $115,200 31,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-14 Sale 10b5-1 −5,000 $52.00 $260,000 26,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-15 Option exercise 10b5-1 +10,000 $23.04 $230,400 36,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-15 Sale 10b5-1 −5,000 $53.00 $265,000 31,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-15 Sale 10b5-1 −5,000 $54.00 $270,000 26,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-16 Option exercise 10b5-1 +10,000 $23.04 $230,400 36,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-16 Sale 10b5-1 −5,000 $55.00 $275,000 31,475 D
Goldshleger Ilya Chief Operating Officer 2024-02-16 Sale 10b5-1 −5,000 $56.00 $280,000 26,475 D
Derivatives
Goldshleger Ilya Chief Operating Officer 2024-02-14 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 20,000 D
Goldshleger Ilya Chief Operating Officer 2024-02-15 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 10,000 D
Goldshleger Ilya Chief Operating Officer 2024-02-16 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0 D
Open-market sales · 25,000 sh · avg $54.00 · $1,350,000
Loading xslF345X05/ownership.xml…